SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Rande Is . . . HOME

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: JLS who wrote (31074)8/2/2000 11:51:23 AM
From: johnsto1  Read Replies (1) of 57584
 
GNSC showing decent strength,in at $15.9
hod $17.25,so far more buyers then flippers.

Aug 01 Genaissance Pharms GNSC 6M 11-13 13 15
Lead Underwriter: Deutsche Bc Alex. Br. Co-managers: Bear Stearns, Salomon Smth Brny, UBS Warburg
Description: Co's HAP Technology is used to examine haplotypes (units of genetic variation) in blood samples
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext